Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2017 | May 15, 2017 | |
Document And Entity Information [Abstract] | ||
Entity Registrant Name | IDdriven, Inc. | |
Entity Central Index Key | 1,605,024 | |
Trading Symbol | iddr | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 117,317,366 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q1 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2017 | Dec. 31, 2016 |
Current Assets | ||
Cash and cash equivalents | $ 120,866 | $ 13,174 |
Accounts receivable | 6,719 | 12,236 |
Other receivables and prepaid expenses | 10,603 | 11,514 |
Total Current Assets | 138,188 | 36,924 |
Property and equipment, net | 3,804 | 4,769 |
Other assets | 16,965 | 16,648 |
TOTAL ASSETS | 158,957 | 58,341 |
Current Liabilities | ||
Accounts payable (including related party payables of $23,305 and $17,152, respectively) | 292,517 | 195,767 |
Accrued expenses | 136,466 | 98,684 |
Accrued interest - related parties | 20,835 | 9,172 |
Deferred revenue and customer deposits | 7,500 | |
Management fees payable - related parties | 390,459 | 296,816 |
Other current liabilities | 77,424 | 27,331 |
Convertible notes payable, net of unamortized debt discount of $267,403 and $414,118, respectively | 985,855 | 756,191 |
Notes payable | 61,000 | 51,000 |
Notes payable - related parties | 39,590 | 38,850 |
Derivative liabilities | 260,771 | 2,577,652 |
Total Current Liabilities | 2,264,917 | 4,058,963 |
TOTAL LIABILITIES | 2,264,917 | 4,058,963 |
Commitments and contingencies | ||
Stockholders' Deficit | ||
Preferred stock: 10,000,000 authorized shares; $0.001 par value Series A convertible preferred stock, $0.001 par value, $1.00 stated value; 808,000 shares designated; 94,333 and 200,279 shares issued and outstanding, respectively. | 95 | 201 |
Common stock: 500,000,000 authorized; $0.001 par value 107,044,378 and 97,457,397 shares issued and outstanding, respectively | 107,045 | 97,457 |
Additional paid in capital | 1,304,018 | 1,171,625 |
Accumulated deficit | (3,497,809) | (5,255,277) |
Accumulated other comprehensive loss | (19,309) | (14,628) |
Total Stockholders' Deficit | (2,105,960) | (4,000,622) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 158,957 | $ 58,341 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) | Mar. 31, 2017 | Dec. 31, 2016 |
Accounts payable including related party payables (in dollars) | $ 23,305 | $ 17,152 |
Convertible notes payable, net of unamortized debt discount (in dollars) | $ 267,403 | $ 414,118 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 500,000,000 | 500,000,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares issued | 107,044,378 | 97,457,397 |
Common stock, shares outstanding | 107,044,378 | 97,457,397 |
Series A convertible preferred stock | ||
Preferred stock, shares authorized | 808,000 | 808,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, stated value per share (in dollars per share) | $ 1 | $ 1 |
Preferred stock, shares issued | 94,333 | 200,279 |
Preferred stock, shares outstanding | 94,333 | 200,279 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Income Statement [Abstract] | ||
Revenues | $ 18,233 | $ 1,732 |
Operating Expenses | ||
General and administration | 127,682 | 159,840 |
Salaries and wages | 53,442 | 94,962 |
Stock based compensation | 28,184 | 50,842 |
Research and development | 29,448 | 30,949 |
Management fees | 122,448 | 124,552 |
Depreciation | 1,047 | 1,386 |
Total operating expenses | 362,251 | 462,531 |
Loss from operations | (344,018) | (460,799) |
Other income (expense) | ||
Interest expense | (245,209) | (23,581) |
Change in fair value of derivative liability | 2,277,306 | (1,176,150) |
Gain on extinguishment of debt | 69,389 | |
Total other income (expense) | 2,101,486 | (1,199,731) |
Net income (loss) before taxes | 1,757,468 | (1,660,530) |
Income tax benefit | ||
Net income (loss) | 1,757,468 | (1,660,530) |
Other comprehensive income (loss) | ||
Foreign currency translation adjustment | (4,681) | (3,199) |
Comprehensive income (loss) | $ 1,752,787 | $ (1,663,729) |
Net income (loss) per common share, Basic and Diluted (in dollars per share) | $ 0.02 | $ (0.02) |
Weighted average number of common shares outstanding, Basic and Diluted (in shares) | 100,563,342 | 75,170,870 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ 1,757,468 | $ (1,660,530) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation | 1,047 | 1,386 |
Stock-based compensation | 28,184 | 50,842 |
Expenses paid by note payable | 5,000 | |
Amortization of debt discount and debt issue cost | 189,845 | 10,479 |
Gain on extinguishment of debt | (69,389) | |
Change in fair value of derivative | (2,277,306) | 1,176,150 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 5,601 | (54) |
Prepaid expenses and other receivables | 1,017 | (23,868) |
Accounts payable | 108,102 | 45,558 |
Accrued interest | 43,699 | 13,033 |
Accrued interest, related parties | 11,663 | |
Deferred revenue | (7,500) | |
Management fees, related parties | 93,433 | |
Other current liabilities | 50,857 | (201) |
Net Cash Used in Operating Activities | (63,279) | (382,205) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchase of property and equipment | (1,458) | |
Net Cash Used in Investing Activities | (1,458) | |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from issuance of convertible note payable | 135,846 | 250,000 |
Proceeds from issuance of promissory notes payable | 10,000 | |
Proceeds from issuance of common shares | 27,300 | |
Proceeds from preferred stock subscription | 245,000 | |
Net Cash Provided By Financing Activities | 173,146 | 495,000 |
Foreign currency translation effect on cash and cash equivalents | (2,175) | 1,226 |
Increase in cash and cash equivalents | 107,692 | 112,563 |
Cash and cash equivalents, beginning of period | 13,174 | 48,764 |
Cash and cash equivalents, end of period | 120,866 | 161,327 |
Supplemental cash flow information | ||
Cash paid for interest | ||
Cash paid for taxes | ||
Supplemental disclosure of non-cash investing and financing activities | ||
Derivative liability recognized as debt discount | 24,631 | 263,879 |
Prepaid expenses paid by note payable | 25,000 | |
Accrued debt issuance cost | $ 17,500 | |
Conversion of Series A Convertible Preferred Stock into common stock | 3,579 | |
Conversion of notes payable and accrued interest into common stock | $ 104,128 |
ORGANIZATION AND BUSINESS
ORGANIZATION AND BUSINESS | 3 Months Ended |
Mar. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BUSINESS | NOTE 1. ORGANIZATION AND BUSINESS Organization and Operations IDdriven, Inc., (“IDdriven”, “we”, “us”, or the “Company”) is a Nevada corporation incorporated on January 27, 2014 under the name TiXFi, Inc. Insight Innovators B.V., was incorporated on May 22, 2013 in the Netherlands and has its registered corporate seat in Amersfoort, The Netherlands. Going Concern Matters The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which contemplates the Company’s continuation as a going concern. The Company has incurred operating losses of $344,018 during the three months ended March 31, 2017 and has an accumulated deficit of $3,497,809 as of March 31, 2017. In addition, current liabilities exceed current assets by $2,126,729 as of March 31, 2017. Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. See Note 15 – Subsequent Events. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists a substantial doubt about the ability of the Company to continue as a going concern. The accompanying unaudited condensed consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation of Interim Financial Statements The accompanying interim unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. Notes to the unaudited interim consolidated financial statements that would substantially duplicate the disclosures contained in the audited consolidated financial statements for fiscal year 2016 have been omitted. This report should be read in conjunction with the audited consolidated financial statements and the footnotes thereto for the fiscal year ended December 31, 2016 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on March 31, 2017. Consolidation Policy For March 31, 2017, the unaudited condensed consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiary, Insight Innovators B.V. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates and Assumptions The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about collection of accounts and notes receivable, the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets. Functional currency The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars (“USD”). The Company’s wholly owned subsidiary (Insight’s) functional currency is the Euro. The financial statements are translated into USD in accordance with Codification ASC 830, “Foreign Currency Matters”. All assets and liabilities were translated at the current exchange rate, at respective balance sheet dates, shareholders’ equity is translated at the historical rates and income statement items are translated at the average exchange rate for the reporting periods. The resulting translation adjustments are reported as other comprehensive income and accumulated other comprehensive income in the shareholders’ equity in accordance with Codification ASC 220, “Comprehensive Income”. Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into Euro at the rate on the date of the transaction and included in the results of operations as incurred. There were no material transaction gains or losses in the periods presented. March 31, 2017 December 31, 2016 Spot Euro: USD exchange rate $ 1.07 $ 1.05 Average Euro: USD exchange rate $ 1.06 $ 1.08–1.12 Cash and cash equivalents Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired. As of March 31, 2017 and December 31, 2016, cash primarily consists of cash on hand and in bank. As of March 31, 2017, cash held in a U.S. bank was $119,010 and cash held in foreign bank in the Netherlands was $1,856 (EUR1,735). As of December 31, 2016, cash held in a U.S. bank was $9,971 and cash held in foreign bank in the Netherlands was $3,203 (EUR3,050). Revenue recognition The Company recognizes revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (“ASC 605-10”) which requires that four basic criteria must be met before revenue can be recognized: (i) persuasive evidence of an arrangement exists; (ii) services have been rendered; (iii) the fee is fixed or is determinable; and (iv) collectability is reasonably assured. Determination of criteria (iii) and (iv) are based on management’s judgments regarding the fixed nature of the selling prices of the services delivered and the collectability of those amounts. The Company’s agreements do not include general rights of return and do not provide clients with the right to take possession of the software supporting the services being provided. As such, the agreements are accounted for as service contracts. Revenues from the services rendered are recognized in proportion to the services delivered. Any amount receivable or received, but unrecognized for revenue recognition purpose is recorded as deferred revenues. Sales taxes collected from clients and remitted to governmental authorities where applicable are accounted for on a net basis and therefore are excluded from revenues in the statements of operations. Share-Based Expense ASC 718, ”Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, ”Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Share-based expense totaled $28,184 and $50,842 for the three months ending March 31, 2017 and 2016, respectively. Fair value measurements Fair value is defined as the price that the Company would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent counter-party in the principal market or in the absence of a principal market, the most advantageous market for the investment or liability. A three-tier hierarchy is established to distinguish between (1) inputs that reflect the assumptions market participants would use in pricing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs) and (2) inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing an asset or liability developed based on the best information available in the circumstances (unobservable inputs); and establishes a classification of fair value measurements for disclosure purposes. The hierarchy is summarized in the three broad levels listed below: Level 1 - quoted prices in active markets for identical assets and liabilities Level 2 - other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.) Level 3 - significant unobservable inputs (including the Company’s own assumptions in determining the fair value of assets and liabilities). In accordance with Accounting Standards Codification (“ASC”) 815, the Company’s debt derivative liabilities are measured at fair value on a recurring basis, and are level 3 measurements in the three-tier fair value hierarchy. There were no transfers between the levels of the fair value hierarchy during the three months ended March 31, 2017 and 2016. Fair value of financial instruments The Company’s financial instruments consist primarily of cash, accounts payable and accrued expenses, and debt. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments. The following table summarizes fair value measurements by level at March 31, 2017 and December 31, 2016 measured at fair value on a recurring basis: March 31, 2017 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 260,771 $ 260,771 December 31, 2016 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 2,577,652 $ 2,577,652 Recently Issued Accounting Standards In February 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-06, “Plan Accounting: Defined Benefit Pension Plans (Topic 960); Defined Contribution Pension Plans (Topic 962); Health and Welfare Benefit Plans (Topic 965): Employee Benefit Plan Master Trust Reporting.” Among other things, the amendments require a plan’s interest in that master trust and any change in that interest to be presented in separate line items in the statement of net assets available for benefits and in the statement of changes in net assets available for benefits, respectively. The amendments also remove the requirement to disclose the percentage interest in the master trust for plans with divided interests and require that all plans disclose the dollar amount of their interest in each of those general types of investments. The amendments require all plans to disclose: (a) their master trust’s other asset and liability balances; and (b) the dollar amount of the plan’s interest in each of those balances. Lastly, the amendments eliminate redundant investment disclosures (e.g., those required by Topics 815 and 820) relating to 401(h) account assets. Effective for fiscal years beginning after December 15, 2018. Early adoption is permitted. The amendments should be applied retrospectively to each period for which financial statements are presented. The Company does not anticipate the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements. In February 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-05, “Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets.” The amendments clarify that a financial asset is within the scope of Subtopic 610-20 if it meets the definition of an in substance nonfinancial asset. The amendments also define the term in substance nonfinancial asset. The amendments clarify that nonfinancial assets within the scope of Subtopic 610-20 may include nonfinancial assets transferred within a legal entity to a counterparty. For example, a parent may transfer control of nonfinancial assets by transferring ownership interests in a consolidated subsidiary. A contract that includes the transfer of ownership interests in one or more consolidated subsidiaries is within the scope of Subtopic 610-20 if substantially all of the fair value of the assets that are promised to the counterparty in a contract is concentrated in nonfinancial assets. The amendments clarify that an entity should identify each distinct nonfinancial asset or in substance nonfinancial asset promised to a counterparty and derecognize each asset when a counterparty obtains control of it. Effective at the same time as the amendments in Update 2014-09, Revenue from Contracts with Customers (Topic 606). Therefore, public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the amendments in this Update to annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities should apply the amendments in this Update to annual reporting periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. All other entities may apply the guidance earlier as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities also may apply the guidance earlier as of annual reporting periods beginning after December 15, 2016, and interim reporting periods within annual reporting periods beginning one year after the annual reporting period in which the entity first applies the guidance. An entity is required to apply the amendments in this Update at the same time that it applies the amendments in Update 2014-09. The Company is currently evaluating the potential impact this standard may have on its financial position and results of operations. In January 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” These amendments eliminate Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. Effective for public business entities that are a SEC filers for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. ASU 2017-04 should be adopted on a prospective basis. The Company does not anticipate the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This new standard clarifies the definition of a business and provides a screen to determine when an integrated set of assets and activities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This new standard will be effective for the Company on January 1, 2018, however, early adoption is permitted with prospective application to any business development transaction. Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements. |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 3 Months Ended |
Mar. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT | NOTE 3. PROPERTY AND EQUIPMENT Property and equipment consisted of the following at March 31, 2017 and December 31, 2016: March 31, December 31, 2017 2016 Furniture $ 5,915 $ 5,915 Computers 18,886 18,886 24,801 24,801 Accumulated Depreciation (18,639 ) (17,593 ) Foreign currency translation effect (2,358 ) (2,439 ) Property and equipment, net $ 3,804 $ 4,769 Depreciation expense for the three months ended March 31, 2017 and 2016 amounted to $1,047 and $1,386, respectively. All of the Company’s property and equipment are recorded in Insight (foreign subsidiary) as of March 31, 2017 and December 31, 2016. |
NOTES PAYABLE
NOTES PAYABLE | 3 Months Ended |
Mar. 31, 2017 | |
Notes Payable [Abstract] | |
NOTES PAYABLE | NOTE 4. NOTES PAYABLE Notes Payable March 31, December 31, 2017 2016 Promissory Notes - December 2016 $ 51,000 $ 51,000 Promissory Notes - January 2017 10,000 - Less current portion of notes payable 61,000 51,000 Long-term notes payable $ - $ - As of March 31, 2017 and December 31, 2016, the accrued interest related to this promissory note was $2,894 and $28, respectively. Dated December 30, 2016 On December 30, 2016, the Company issued a 20% Promissory Note for $51,000. The note bears interest at a rate of 20% per annum and the maturity date is the twelve months from the issue date. Dated January 26, 2017 On January 26, 2017, the Company issued a 20% Promissory Note for $10,000. The note bears interest at a rate of 20% per annum and the maturity date is the twelve months from the issue date. Notes Payable – Related Parties Notes payable – related party consisted of the following at March 31, 2017 and December 31, 2016: March 31, December 31, 2017 2016 Promissory Notes $ 39,590 $ 38,850 Less current portion of notes payable 39,590 38,850 Long-term notes payable $ - $ - Dated June 29, 2016 On June 29, 2016, the Company issued an 8% Promissory Note for EUR 10,000 ($10,700). The note bears interest at a rate of 8% per annum and is due within ten days after demand by the lender. Dated June 30, 2016 On June 30, 2016, the Company issued an 8% Promissory Note for EUR 10,000 ($10,700). The note bears interest at a rate of 8% per annum and is due within ten days after demand by the lender. Dated August 29, 2016 On August 29, 2016, the Company issued an 8% Promissory Note for EUR 35,000 ($37,450). The note bears interest at a rate of 8% per annum and is due within ten days after demand by the lender. EUR18,000 ($18,900) of note was repaid in December 2016. As of March 31, 2017 and December 31, 2016, the accrued interest related to these promissory notes - related party was $2,866 and $2,046, respectively. |
CONVERTIBLE NOTES PAYABLE
CONVERTIBLE NOTES PAYABLE | 3 Months Ended |
Mar. 31, 2017 | |
Convertible Notes Payable [Abstract] | |
CONVERTIBLE NOTES PAYABLE | NOTE 5. CONVERTIBLE NOTES PAYABLE Convertible notes payable consisted of the following at March 31, 2017 and December 31, 2016: March 31, December31, 2017 2016 Convertible Note - December 2015 $ 350,000 $ 350,000 Convertible Note - February 2016 - 30,000 Convertible Note - March 2016 250,000 250,000 Convertible Notes - May 2016 62,500 75,000 Convertible Note - June 2016 15,000 15,000 Convertible Notes - September 2016 176,510 201,511 Convertible Notes -October 2016 130,748 148,798 Convertible Notes - November 2016 25,000 25,000 Convertible Notes - December 2016 75,000 75,000 Convertible Notes - March 2017 168,500 - 1,253,258 1,170,309 Less debt discount and debt issuance cost (267,403 ) (414,118 ) 985,855 756,191 Less current portion of convertible notes payable 985,855 756,191 Long-term convertible notes payable $ - $ - The Company recognized amortization expense related to the debt discount and deferred financing fees of $189,845 and $10,479 for the three months ended March 31, 2017 and 2016, respectively, which are included in interest expense in the consolidated statements of operations. 10% Convertible Note – December 2015 On December 21, 2015, the Company issued a 10% Convertible Note (the “10% Convertible Note”) in the amount of $500,000, in exchange for a promissory note for $500,000 originally issued by Insight on October 20, 2015 to an unrelated third party investor (the “Investor”). The company assumed accrued interest of $3,838 due from this previous promissory note. The 10% Convertible Note bears interest at the rate of 10% per annum and matures May 1, 2017. The holder is entitled to convert any portion of the outstanding and unpaid conversion amount in to fully paid and non-assessable shares of Common Stock. The conversion price (the “Conversion Price”) is 75% of the volume weighted average price of the Common Stock for the ten (10) trading days immediately prior to the applicable conversion date, subject to adjustment herein but in no event: (i) lower than $4,000,000 divided by the total number of shares of Common Stock outstanding immediately prior to the conversion date; or (ii) greater than $12,000,000 divided by the total number of shares of common stock outstanding immediately prior to the conversion date. On July 22, 2016, $150,000 of the Convertible Note was converted into 941,620 common shares at market trading price $0.27 per share. $160,771 value of derivative liability on the date of conversion was extinguished and the conversion generated $56,534 gain on extinguishment of debt in the consolidated statements of operations. Additional features of the 10% Convertible Note include: · Liquidation Preference · Mandatory Conversion · Ownership Limitations · Certain Adjustments · Negative Covenants · Redemption Upon Triggering Events · Piggy-Back Registration Rights. Dated – Issued in Fiscal Year 2016 During the year ended December 31, 2016, the Company issued a total Convertible Notes in the amount of $820,308 and warrants to purchase up to 450,755 shares of our common stock, with the following terms: · Terms 6 – 18 months · Annual interest rates ranging from 8% to 20% · Convertible at the option of the holders either at issuance or 6 months from issuance. · Conversion prices are typically based on the discounted (20% - 25% discount) lowest trading prices of the Company’s shares during various periods prior to conversion. Certain notes are subject to adjustment to not convert in a value band, not lower than $4,000,000 to $6,000,000 or higher than $12,000,000 to $18,000,000, divided by the total number of shares of common stock outstanding immediately prior to the conversion date. Dated – Issued in 1 st During the three months ended March 31, 2017, the Company issued a Convertible Note to EMA Financial, LLC (“Purchaser”) in the amount of $168,500 (the “Note”) with the following terms: · Term 1 year · Annual interest rate 10% · Convertible at the option of the holders either at issuance or 1 year from issuance · Conversion price is $0.04 per share · Financing cost on note issuance at $18,500 The Note is convertible into common stock, subject to Rule 144, at any time after the issue date of the Note at a conversion price of $0.04 per share of the Company’s Common Stock provided however, if the Company fails to comply with Section 1.9 of the Note (described below), then the conversion price (“Default Conversion Price”) shall equal the lower of: (i) the closing sale price of Common Stock on the Principal Market on the Trading Day immediately preceding the Closing Date, and (ii) 60% of either the lowest sale price for the Common Stock on the Principal Market during the twenty (20) consecutive Trading Days immediately preceding the Conversion Date or the closing bid price, whichever is lower, provided, however, if the Company’s share price at any time loses the bid (ex: 0.0001 on the ask with zero market makers on the bid on level 2), then the Conversion Price may, in the Purchaser's sole and absolute discretion, be reduced to a fixed conversion price of 0.00001 (if lower than the conversion price otherwise), and provided, that if on the date of delivery of the Conversion Shares to the Purchaser, or any date thereafter while Conversion Shares are held by the Purchaser, the closing bid price per share of Common Stock on the Principal Market on the Trading Day on which the Common Shares are traded is less than the sale price per share of Common Stock on the Principal Market on the Trading Day used to calculate the Conversion Price hereunder, then such Conversion Price shall be automatically reduced such that the Conversion Price shall be recalculated using the new low closing bid price (“Adjusted Conversion Price”) and shall replace the Conversion Price above, and Purchaser shall be issued a number of additional shares such that the aggregate number of shares Purchaser receives is based upon the Adjusted Conversion Price, and provided, further, that the Conversion Price shall be subject to further adjustment in Section 1.2(b) of the Note. Purchaser does not have the right to convert the Note, to the extent that it would beneficially own in excess of 4.9% of the Company's outstanding common stock. If an Event of Default under Section 3.9 of the Note has occurred (i.e., failure to comply with the Exchange Act), Purchaser, in its sole discretion, may elect to use a Conversion Price which shall equal the lower of: (i) the closing sale price of the Common Stock on the Principal Market on the Trading Day immediately preceding the Closing Date; (ii) 60% of either the lowest sale price or the closing bid price, whichever is lower for the Common Stock on the Principal Market during any Trading Day in which the Event of Default has not been cured. If such Common Stock is not traded on the OTCBB, OTCQB, NASDAQ or NYSE, then such sale price shall be the sale price of such security on the principal securities exchange or trading market where such security is listed or traded or, if no sale price of such security is available in any of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the “pink sheets” by the National Quotation Bureau, Inc. If such sale price cannot be calculated for such security on such date in the manner provided above, such price shall be the fair market value as mutually determined by the Company and the Purchaser. If the Company’s Common stock is chilled for deposit at DTC, becomes chilled at any point while this Note remains outstanding or deposit or other additional fees are payable due to a Yield Sign, Stop Sign or other trading restrictions, or if the closing sale price at any time falls below $0.01 (as appropriately and equitably adjusted for stock splits, stock dividends, stock contributions and similar events), then such 60% figure specified above shall be reduced to 45%. In the event that the shares of the Company’s Common Stock are not deliverable via DWAC following the conversion of any amount hereunder, an additional 5% discount will be attributed to the Conversion Price. Additionally, the Company acknowledges that it will take all reasonable steps necessary or appropriate, including providing a board of directors resolution authorizing the issuance of common stock to Purchaser. The Company determined that the conversion feature met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock therefore the embedded conversion option is bifurcated once the note becomes convertible and accounted for it as a derivative liability. The fair value of the conversion feature is recorded as a debt discount and amortized to interest expense over the term of the note. The Company valued the conversion feature using the Black Scholes valuation model. The fair value of the derivative liability for all the notes and warrants that became convertible as of March 31, 2017 and December 31, 2016 amounted to $260,771 and $2,577,652, respectively. During the three months ended March 31, 2017 and 2016, $24,631 and $263,879 of the value assigned to the derivative liability was recognized as a debt discount to the notes and warrants, $0 and $284,380 was recognized as a “day 1” derivative loss, respectively. During the three months ended March 31, 2017, convertible notes totaled $85,550 and $6,023 accrued interest were converted into 4,642,725 common shares with the recognition of gain on note conversion at $69,389. Warrants We accounted for the issuance of the Warrants in accordance with ASC 815 as a derivative (see Note 6). Fiscal Year 2016 On March 28, 2016, the Company issued a Convertible Note in the amount of $250,000 and warrants to purchase up to 250,000 shares of our common stock. The warrants are exercisable into 250,000 shares of common stock, for a period of five years from issuance, at a price of $0.40 per share. On September 12, 2016, the Company issued a Convertible Note in the amount of $101,511 and warrants to purchase up to 50,755 shares of our common stock. The warrants are exercisable into 50,775 shares of common stock, for a period of one year from issuance, at 120% of the lowest trading price during 20 trading day prior to the exercise date. On September 12, 2016, the Company issued a Convertible Note in the amount of $150,000 of which $150,000 was received as of December 31, 2016, and warrants to purchase up to 75,000 shares of our common stock. The warrants are exercisable into 75,000 shares of common stock, for a period of one year from issuance, at 120% of the lowest trading price during 20 trading day prior to the exercise date. On September 21, 2016, the Company issued Convertible Notes in the amount of $150,000 of which $150,000 was received as of December 31, 2016, and warrants to purchase up to 75,000 shares of our common stock. The warrants are exercisable into 75,000 shares of common stock, for a period of one year from issuance, at 120% of the lowest trading price during 20 trading day prior to the exercise date. 1 st During the three months ended March 31, 2017, the Company issued a total of 3,136,500 stock warrants as follows: · On January 30, 2017, the Company entered into a public relations agreement with an unaffiliated party with warrants to purchase up to 2,000,000 shares of common stock. The warrants are exercisable into 2,000,000 shares of common stock, for a period of 3 years, at a price of $0.25 per share. The 2,000,000 warrants are considered tainted and the Company has recorded the related derivative liability. · On February 21, 2017, the Company entered into a consulting agreement with an unaffiliated party with warrants to purchase up to 1,000,000 shares of common stock. The warrants will be vested and can be exercised into 1,000,000 shares of common stock in 3 months from the agreement date by May 21 2017, for a period of three years from issuance, at a price of $0.02 per share. The related derivative liability for the 1,000,000 warrants will be recorded in May 2017 when they become tainted. · On February 28, 2017, the Company entered into a share subscription agreement with an unaffiliated party with attached warrants to purchase up to 136,500 shares of common stock. The warrants are exercisable into 136,500 shares of common stock, for a period of two years from issuance, at a price of $0.02 per share. The 136,500 warrants are considered tainted and the Company has recorded the related derivative liabilities. The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2017: Warrants Outstanding Warrants Exercisable Number of Shares Weighted Average Remaining Contractual life Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price 3/28/2016 250,000 3.99 $ 0.40 250,000 $ 0.40 9/12/2016 75,000 2.42 0.0211 75,000 0.0211 9/12/2016 50,755 2.42 0.0211 50,755 0.0211 9/21/2016 75,000 2.45 0.0211 75,000 0.0211 1/30/2017 2,000,000 2.84 0.2500 2,000,000 0.2500 2/21/2017 1,000,000 0.90 0.0200 - - 2/28/2017 124,000 1.92 0.0200 124,000 0.0200 2/28/2017 12,500 1.92 0.0200 12,500 0.0200 3,587,255 2,587,255 Warrants Outstanding Weighted Average Shares Exercise Price Balances as of December 31, 2016 450,755 $ 0.23 Granted 3,136,500 0.17 Exercised - - Forfeited/canceled - - Balances as of March 31, 2017 3,587,255 $ 0.17 |
DERIVATIVE LIABILITIES
DERIVATIVE LIABILITIES | 3 Months Ended |
Mar. 31, 2017 | |
Derivative Liability [Abstract] | |
DERIVATIVE LIABILITIES | NOTE 6. DERIVATIVE LIABILITIES The Company analyzed the conversion option for derivative accounting consideration under ASC 815, ” Derivatives and Hedging,” The Company determined our derivative liabilities to be a Level 3 fair value measurement and used the Black-Scholes pricing model to calculate the fair value as of March 31, 2017. The Black-Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each convertible note and warrants is estimated using the Black-Scholes valuation model. The following weighted-average assumptions were used in March 31, 2017 and December 31, 2016: Three Months Ended Year Ended March 31, 2017 December 31, 2016 Expected term 0.08 - 3.99 years 0.10 - 5.00 years Expected average volatility 113% - 151% 98% - 169% Expected dividend yield - - Risk-free interest rate 0.67%-1.72% 0.36% - 1.93% The following table summarizes the derivative liabilities included in the balance sheet at March 31, 2017: Fair Value Measurements Using Significant Observable Inputs (Level 3) Balance - December 31, 2016 $ 2,577,652 Addition of new derivative liabilities upon issuance of convertible notes as debt discounts 24,631 Addition of new derivatives liabilities recognized as issuance of warrants as stock based compensation expense 17,737 Reduction of derivatives liabilities from conversion of convertible note to common shares (81,943 ) Gain on change in fair value of the derivative liabilities (2,277,306 ) Balance – March 31, 2017 $ 260,771 ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The following table summarizes the loss on derivative liability included in the income statement for the three months ended March 31, 2017 and 2016, respectively. Three Months Ended March 31, 2017 2016 Day one loss due to derivative liabilities on convertible notes and warrants $ - $ 284,380 (Gain) Loss on change in fair value of the derivative liabilities (2,277,306 ) 891,770 (Gain) Loss on change in the fair value of derivative liabilities $ (2,277,306 ) $ 1,176,150 |
RELATED PARTY CONSIDERATIONS
RELATED PARTY CONSIDERATIONS | 3 Months Ended |
Mar. 31, 2017 | |
Related Party Transactions [Abstract] | |
RELATED PARTY CONSIDERATIONS | NOTE 7. RELATED PARTY CONSIDERATIONS Management Agreements Insight entered into Management Agreements with Berlisa B.V., Eagle Consulting LLC and Sterling Skies B.V. (entities that are owned by Messrs. Verweij, van Wijk and de Vries, executive officers of our company and related parties) on July 1, 2014 for a period of one year which expired on June 30, 2015 with a monthly fee of €7,500 per month. The Company charged $122,448 and $124,552 during the three months ended March 31, 2017 and 2016, respectively to operations for the management fees stemming from these Management Agreements. As of March 31, 2017 and December 31, 2016, the amount due to related parties was $390,459 and $296,816 and accrued interest on the payable amount of $20,835 and $9,172, respectively. |
CONCENTRATIONS
CONCENTRATIONS | 3 Months Ended |
Mar. 31, 2017 | |
Risks and Uncertainties [Abstract] | |
CONCENTRATIONS | NOTE 8. CONCENTRATIONS The following table sets forth information as to each customer that accounted for 10% or more of the Company’s revenues for the three months ended March 31, 2017 and 2016. In 2015 Insight Innovators decided to stop with consultancy and move forward as a product company. Three Months Ended Three Months Ended Customer March 31, 2017 March 31, 2016 EU PWN 59 % 100 % US NRECA 41 % - $10,733 of our total sales of $18,233 was generated in foreign countries by Insight during the three months ended March 31, 2017. All of our sales were generated in foreign countries by Insight during the three months ended March 31, 2016. |
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT | 3 Months Ended |
Mar. 31, 2017 | |
Stockholders' Equity Attributable to Parent [Abstract] | |
STOCKHOLDERS' DEFICIT | NOTE 9. STOCKHOLDERS’ DEFICIT Preferred Stock The Company has authorized 10,000,000 preferred shares with a par value of $0.001 per share. The Board of Directors is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes. Series A Convertible Preferred Stock The Company has designated 808,000 shares of Series A Convertible Preferred Stock. The designations, rights and preferences of the Series A Preferred include: · the stated value of the Series A Preferred is $1.00 per share. · the shares have no voting rights, provided, however, that for so long as any shares are outstanding, we many not, without the affirmative vote of at least 51% of the then outstanding shares of the Series A Preferred, (a) alter or change adversely the powers, preferences or rights given to the Series A Preferred or alter or amend the Certificate of Designation, (b) authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation (as defined) senior to, or otherwise in pari passu · each share is convertible at the option of the holder based upon a conversion price of $0.1778 ($0.0296 per share post forward stock split), into shares of our common stock at any time. The rate of conversion is subject to adjustment as discussed below. · Upon our liquidation, dissolution or winding-up, the holders will be entitled to receive out of our assets, whether capital or surplus, an amount equal to the stated value per share, $1.00, plus any accrued and unpaid dividends thereon. · the conversion price of the Series A Preferred is subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events by adjustment of the conversion price by its multiplication by a fraction the numerator of which is the number of shares of common stock outstanding immediately before such event, and the denominator of which is the number of shares outstanding immediately after such event. · If, at any time while the Series A Preferred is outstanding, the Company or any subsidiary, as applicable sells or grants any option to purchase or sells or grants any right to re-price, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any common stock or common stock equivalents entitling any person to acquire shares of common stock at an effective price per share that is lower than a conversion price then in effect for any of the Series A Preferred, as adjusted, then the conversion price for shares of Series A Preferred shall be reduced to equal the lower issuance price. · As long as any shares of Series A Preferred are outstanding, unless the holders of at least 51% in Stated Value of the then outstanding shares of such Series A Preferred shall have given prior written consent, the Corporation shall not, and shall not permit any Subsidiary to, directly or indirectly: a) The Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its subsidiaries of common stock or common stock equivalents (or a combination of units thereof) involving a variable rate transaction. “Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of common stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of common stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the common stock or (ii) enters into any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price. During the three months ended March 31, 2017, 105,946 shares of Series A Convertible Preferred Stock were converted into 3,579,256 shares of common stock. As of March 31, 2017 and December 31, 2016, the Company had 94,333 and 200,279, respectively, shares of Series A Convertible preferred stock issued and outstanding, respectively. Common Stock The Company has authorized 500,000,000 common shares with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. During the three months ended March 31, 2017, the Company issued 9,586,981 shares of common stock, as follows: · 1,365,000 shares of common stock issued for net proceeds of $27,300. · 3,579,256 shares of common stock in a conversion of 105,946 shares of Series A Convertible Preferred Stock. · 4,642,725 shares of common stock in a conversion of $85,550 of Convertible Notes and accrued interest $6,023 valued at $104,128. As at March 31, 2017 and December 31, 2016, the Company had 107,044,378 and 97,457,397 shares of common stock issued and outstanding, respectively. |
INCENTIVE STOCK PLANS
INCENTIVE STOCK PLANS | 3 Months Ended |
Mar. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
INCENTIVE STOCK PLANS | NOTE 10. INCENTIVE STOCK PLANS 2015 Stock Option Grants We granted stock options, which was adopted by our board of directors on December 21, 2015, provides for equity incentives to be granted to our employees, executive officers or directors. During the year ended December 31, 2015 we issued options to purchase an aggregate of 8,173,686 shares of our unregistered common stock at a price of $.04893 per share for 1/3 of the shares, $.05873 per share for 1/3 of the shares, and $.06852 per share for 1/3 of the shares. The options had an aggregate value totaling $71,630 were issued to Messrs. Verweij, van Wijk and de Vries, executive officers of our company. A summary of activity during the three months ended March 31, 2017 follows: Options Outstanding Weighted- Fair Value Number of Average on Grant Intrinsic Shares Exercise Price Date Value Balances as of December 31, 2016 8,173,686 $ 0.0587 $ 71,630 $ 2,997 Granted - - - - Exercised - - - - Forfeited/canceled - - - - Balances as of March 31, 2017 8,173,686 $ 0.0587 $ 71,630 $ - The outstanding options have a weighted-average remaining contract term of 3.73 years. As of March 31, 2017, all options remain unvested. One-third of the options granted vest at the end of the first, second and third year after the date of the award date of December 21, 2015. After vesting, the option generally can be exercised for the period remaining in the 5-year term from issuance date. Total compensation cost expected to be recognized for unvested options at March 31, 2017 amounted to $22,568. During the three months ended March 31, 2017 and 2016, the Company charged to operations stock based compensation expense of $4,910 and $10,842, respectively. Year Ended December 31, 2015 Expected term 5 years Expected average volatility 95 % Expected dividend yield - Risk-free interest rate 1.67 % Expected annual forfeiture rate - The following table summarizes information relating to outstanding and exercisable stock options as of March 31, 2017: Options Outstanding Options Exercisable Number of Shares Weighted Average Remaining Contractual life (in years) Weighted Average Number of Shares Weighted Average 8,173,686 3.73 $ 0.0587 2,724,562 $ 0.0489 Aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the stock options at March 31, 2017 for those stock options for which the quoted market price was in excess of the exercise price (“in-the-money options”). As of March 31, 2017, 2,724,562 options to purchase shares of common stock were exercisable and the intrinsic values of these options are $nil. As of March 31, 2017, the intrinsic value of 5,449,124 outstanding options is nil, as these options to employees vest in the future periods. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 11. COMMITMENTS AND CONTINGENCIES Rent commitment Insight leases approximately 4,000 square feet of space at Nijverheidsweg Noord 78, 3812PM Amersfoort, The Netherlands. The terms of the lease require that Insight pay €1,500 per month (approximately $1,590 per month) on a month to month basis. Total rent expenses for the three months ended March 31, 2017 and 2016 were $4,770 and $4,995, respectively. Rent payable as of March 31, 2017 and December 31, 2016 amounted to $23,305 and $17,152, respectively and included under accounts payable in the consolidated balance sheet. Employment Agreements Arend D. Verweij Additionally, Mr. Verweij is eligible to receive a performance bonus during each year of employment of up to 100% of the base salary. The award of each year’s performance bonus, if any, is to be based upon certain performance criteria specified in the employment agreement and to be further determined by a majority of the independent members of the board of directors or a compensation committee to be made up of at least a majority of independent members appointed by the board or directors. Moreover, Mr. Verweij will receive a stock option grant entitling him to purchase an aggregate of 3,065,130 shares of our common stock which vests one-third on each of the three anniversary dates of his employment, but only if he is still in our employ on the date of vesting. The exercise prices of the option shares as to one third their number on their three respective vesting anniversaries are $0.04893, $0.05873 and $0.06852 per share. The number of unvested option shares available as of a given time during his employ are subject to appropriate adjustment in the event we undertake or undergo, as applicable, a stock split, reverse stock split, merger, recapitalization and similar transactions, and should Mr. Verweij cease to be in our employ, except for under certain specified circumstances, he will have one month to exercise vested options or otherwise they will become void. Those certain specified circumstances are his termination by us without cause, his termination for good reason, or his termination by reason of a change in control. Further, Mr. Verweij shall be entitled to five weeks’ paid vacation, as well as in respect of all conventional holidays, a $1,500 monthly health insurance allowance, reimbursement of his out of pocket expenses incurred in connection with his employment, and such other perquisites and benefits as are or as may be made available to other of our executive employees. As of the date of this report, the board of directors has not established a complete set of performance benchmarks for purposes of determining bonuses payable to Mr. Verweij or other of our executives. If Mr. Verweij’s employment is terminated by us, for cause, or by Mr. Verweij without good reason, he shall be entitled to be paid his accrued salary through, and earned but unused compensated absence time as of, the date of termination, but all remaining unvested stock options will be immediately forfeited by him. Should we terminate Mr. Verweij’s employment without cause, or should he terminate the same for good reason, he shall be entitled to (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. Finally, during the term of his employment and for a period of (i) one year thereafter if we terminate his employment without cause or he terminates his employment for good reason or (ii) two years otherwise, Mr. Verweij agreed to not engage in any competitive business or activities anywhere in the world, and during and subsequent to his employment, he has agreed to keep certain of our important or sensitive information confidential. Geurt van Wijk Additionally, Mr. van Wijk is eligible to receive a performance bonus during each year of employment of up to 75% of the base salary. The award of each year’s performance bonus, if any, is to be based upon certain performance criteria specified in the employment agreement and to be further determined by a majority of the independent members of the board of directors or a compensation committee to be made up of at least a majority of independent members appointed by the board or directors. Moreover, Mr. van Wijk will receive a stock option grant entitling him to purchase an aggregate of 2,554,278 shares of our common stock which vest one-third on each of the three anniversary dates of his employment, but only if he is still in our employ on the vesting dates. The exercise prices of the option shares as to one third their number on their three respective vesting anniversaries are $0.04893, $0.05873 and $0.06852 per share. The number of unvested option shares available as of a given time during his employ are subject to appropriate adjustment in the event we undertake or undergo, as applicable, a stock split, reverse stock split, merger, recapitalization and similar transactions, and should Mr. van Wijk cease to be in our employ, except for under certain specified circumstances, he will have one month to exercise vested options or otherwise they will become void. Those certain specified circumstances are his termination by us without cause, his termination for good reason, or his termination by reason of a change in control. Further, Mr. van Wijk shall be entitled to five weeks’ paid vacation, as well as in respect of all conventional holidays, a EURO 1,350 monthly vehicle allowance, which will stop when his annual base salary reaches EURO 150,000, reimbursement of his out of pocket expenses incurred in connection with his employment, and such other perquisites and benefits as are or as may be made available to other of our executive employees. As of the date of this report, the board of directors has not established a complete set of performance benchmarks for purposes of determining bonuses payable to Mr. van Wijk or other of our executives. If Mr. van Wijk’s employment is terminated by us, for cause, or by Mr. van Wijk without good reason, he shall be entitled to be paid his accrued salary through, and earned but unused compensated absence time as of, the date of termination, but all remaining unvested stock options will be immediately forfeited by him. Should we terminate Mr. van Wijk’s employment without cause, or should he terminate the same for good reason, he shall be entitled to (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. Finally, during the term of his employment and for a period of (i) one year thereafter if we terminate his employment without cause or he terminates his employment for good reason or (ii) two years otherwise, Mr. van Wijk agreed to not engage in any competitive business or activities anywhere in the world, and during and subsequent to his employment, he has agreed to keep certain of our important or sensitive information confidential. Remy de Vries Additionally, Mr. de Vries is eligible to receive a performance bonus during each year of employment of up to 75% of the base salary. The award of each year’s performance bonus, if any, is to be based upon certain performance criteria specified in the employment agreement and to be further determined by a majority of the independent members of the board of directors or a compensation committee to be made up of at least a majority of independent members appointed by the board or directors. Moreover, Mr. de Vries will receive a stock option grant entitling him to purchase an aggregate of 2,554,278 shares of our common stock which vest one-third on each of the anniversary dates of his employment, but only if he is still in our employ on the vesting date. The exercise prices of the option shares as to one third their number on their three respective vesting anniversaries are $0.04893, $0.05873 and $0.06852 per share. The number of unvested option shares available as of a given time during his employ are subject to appropriate adjustment in the event we undertake or undergo, as applicable, a stock split, reverse stock split, merger, recapitalization and similar transactions, and should Mr. de Vries cease to be in our employ, except for under certain specified circumstances, he will have one month to exercise vested options or otherwise they will become void. Those certain specified circumstances are his termination by us without cause, his termination for good reason, or his termination by reason of a change in control. Further, Mr. de Vries shall be entitled to five weeks’ paid vacation, as well as in respect of all conventional holidays, a EURO 1,350 monthly vehicle allowance, which will stop when his annual base salary reaches EURO 150,000, reimbursement of his out of pocket expenses incurred in connection with his employment, and such other perquisites and benefits as are or as may be made available to other of our executive employees. As of the date of this report, the board of directors has not established a complete set of performance benchmarks for purposes of determining bonuses payable to Mr. de Vries or other of our executives. If Mr. de Vries’ employment is terminated by us, for cause, or by Mr. de Vries without good reason, he shall be entitled to be paid his accrued salary through, and earned but unused compensated absence time as of, the date of termination, but all remaining unvested stock options will be immediately forfeited by him. Should we terminate Mr. de Vries’ employment without cause, or should he terminate the same for good reason, he shall be entitled to (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. Finally, during the term of his employment and for a period of (i) one year thereafter if we terminate his employment without cause or he terminates his employment for good reason or (ii) two years otherwise, Mr. de Vries agreed to not engage in any competitive business or activities anywhere in the world, and during and subsequent to his employment, he has agreed to keep certain of our important or sensitive information confidential. Litigation From time to time we may be a defendant and/or plaintiff in various other legal proceedings arising in the normal course of our business. We are currently not a party to any material legal proceedings or government actions, including any bankruptcy, receivership, or similar proceedings. In addition, we are not aware of any known litigation or liabilities involving the operators of our properties that could affect our operations. Furthermore, as of the date, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2017 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 12. SUBSEQUENT EVENTS Issuance of Common Stock Subsequent to March 31, 2017, the Company issued 10,272,988 shares of common stock for the conversion of convertible notes in the principal amount of $68,884. Convertible Notes The Company sold to AUCTUS FUND, LLC, a Delaware limited liability company (the “Purchaser”) a 10% Convertible Note in the principal amount of $168,500 (the “Note”) for a purchase price of $168,500. The Note was funded and the transaction closed on April 12, 2017. The Note matures on January 10, 2018 (the “Maturity Date”). Interest accrues daily on the outstanding principal amount of the Note at a rate per annum equal to 10% on the basis of a 365-day year. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of twenty-four (24%) per annum. The principal amount of the Note and interest are payable on the Maturity Date. The Note is convertible into common stock, subject to Rule 144, at any time after the issue date of the Note at a conversion price of $0.04 per share of the Company’s Common Stock, subject to adjustment as set forth in Sections 1.2 – 1.9 of the Note therein, including, without limitation Prepayment of the Note pursuant to Section 1.9 therein. Effective on May 2, 2017 the Company sold to Crown Bridge Partners, LLC (“Investor”) a convertible promissory note in the principal amount of $55,000 for a purchase price of $45,000. The Note bears interest at the rate of 1% per year. The Note matures on April 10, 2018. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of twenty-two (22%) per annum. The principal amount of the Note and interest are payable on its maturity date. The Investor is entitled to, at any time or from time to time, convert the Note into shares of the Company’s common stock, at a conversion price per share equal to seventy five percent (75%) of the lowest traded price of the common stock for the twenty (20) trading days immediately preceding the date of the date of conversion, upon the terms and subject to the conditions of the Note. The conversion price of the Note is subject to adjustment in the event of stock splits, stock dividends and similar corporate events. In addition, the conversion price is subject to adjustment if we issue or sell convertible promissory notes that are convertible for a consideration per share less than the conversion price then in effect or includes a longer look back period than provided in the Note. If this should occur, the conversion price is reduced to the lowest price at which these securities were issued or are exercisable or in the case of a more favorable look back period, the look back period shall be adjusted to such greater number of days. The Note contains representations, warranties, events of default, beneficial ownership limitations, prepayment options, and other provisions that are customary of similar instruments. The Note is not convertible to the extent that (a) the number of shares of the Company’s common stock beneficially owned by the Investor and (b) the number of shares of the Company’s common stock issuable upon the conversion of the Note or otherwise would result in the beneficial ownership by Investor of more than 4.99% of the Company’s then outstanding common stock. This ownership limitation can be increased or decreased to any percentage not exceeding 9.99% by the Investor upon a notice of 61 days to us. Series B Preferred Stock On May 11, 2017, the Company filed a certificate of designation, preferences and rights of Series B Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Nevada to designate 1,500,000 shares of its previously authorized preferred stock as Series B Preferred Stock. The holders of shares of Series B Preferred Stock that are not entitled to dividends or distributions have the following voting rights: · Each share of Series B Preferred Stock entitles the holder to 250 votes on all matters submitted to a vote of the Company’s stockholders. In the event that such votes do not total at least 51% of all votes, then the votes cast by the holders of the Series B Preferred Stock shall be equal to 51% of all votes cast at any meeting of the Company’s stockholders or any issue put to the stockholders for voting. · Except as otherwise provided in the Certificate of Designation, the holders of Series B Preferred Stock, the holders of Company common stock and the holders of shares of any other Company capital stock having general voting rights and shall vote together as one class on all matters submitted to a vote of the Company’s stockholders. · The holders of the Series B Preferred Stock do not have any conversion rights. On May 12, 2017, the Company entered into investment agreements (the “Investment Agreements”) with three entities in which Arend D. Verweij, Geurt van Wijk and Remy de Vries, individuals who are either executive officers and directors or both of the Company, have a pecuniary interest in and exercise voting and dispositive control over. Pursuant to the terms of each of the respective Investment Agreements, the Company sold to each of the three entities 500,000 shares of the Series B Preferred Stock at a purchase price of $500 ($0.001 per share). |
SIGNIFICANT ACCOUNTING POLICI18
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Basis of Presentation of Interim Financial Statements | Basis of Presentation of Interim Financial Statements The accompanying interim unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. Notes to the unaudited interim consolidated financial statements that would substantially duplicate the disclosures contained in the audited consolidated financial statements for fiscal year 2016 have been omitted. This report should be read in conjunction with the audited consolidated financial statements and the footnotes thereto for the fiscal year ended December 31, 2016 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on March 31, 2017. |
Consolidation Policy | Consolidation Policy For March 31, 2017, the unaudited condensed consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiary, Insight Innovators B.V. All significant intercompany balances and transactions have been eliminated in consolidation. |
Use of Estimates and Assumptions | Use of Estimates and Assumptions The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about collection of accounts and notes receivable, the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets. |
Functional currency | Functional currency The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars (“USD”). The Company’s wholly owned subsidiary (Insight’s) functional currency is the Euro. The financial statements are translated into USD in accordance with Codification ASC 830, “Foreign Currency Matters”. All assets and liabilities were translated at the current exchange rate, at respective balance sheet dates, shareholders’ equity is translated at the historical rates and income statement items are translated at the average exchange rate for the reporting periods. The resulting translation adjustments are reported as other comprehensive income and accumulated other comprehensive income in the shareholders’ equity in accordance with Codification ASC 220, “Comprehensive Income”. Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into Euro at the rate on the date of the transaction and included in the results of operations as incurred. There were no material transaction gains or losses in the periods presented. March 31, 2017 December 31, 2016 Spot Euro: USD exchange rate $ 1.07 $ 1.05 Average Euro: USD exchange rate $ 1.06 $ 1.08–1.12 |
Cash and cash equivalents | Cash and cash equivalents Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired. As of March 31, 2017 and December 31, 2016, cash primarily consists of cash on hand and in bank. As of March 31, 2017, cash held in a U.S. bank was $119,010 and cash held in foreign bank in the Netherlands was $1,856 (EUR1,735). As of December 31, 2016, cash held in a U.S. bank was $9,971 and cash held in foreign bank in the Netherlands was $3,203 (EUR3,050). |
Revenue recognition | Revenue recognition The Company recognizes revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (“ASC 605-10”) which requires that four basic criteria must be met before revenue can be recognized: (i) persuasive evidence of an arrangement exists; (ii) services have been rendered; (iii) the fee is fixed or is determinable; and (iv) collectability is reasonably assured. Determination of criteria (iii) and (iv) are based on management’s judgments regarding the fixed nature of the selling prices of the services delivered and the collectability of those amounts. The Company’s agreements do not include general rights of return and do not provide clients with the right to take possession of the software supporting the services being provided. As such, the agreements are accounted for as service contracts. Revenues from the services rendered are recognized in proportion to the services delivered. Any amount receivable or received, but unrecognized for revenue recognition purpose is recorded as deferred revenues. Sales taxes collected from clients and remitted to governmental authorities where applicable are accounted for on a net basis and therefore are excluded from revenues in the statements of operations. |
Share-Based Expense | Share-Based Expense ASC 718, ”Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, ”Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Share-based expense totaled $28,184 and $50,842 for the three months ending March 31, 2017 and 2016, respectively. |
Fair value measurements | Fair value measurements Fair value is defined as the price that the Company would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent counter-party in the principal market or in the absence of a principal market, the most advantageous market for the investment or liability. A three-tier hierarchy is established to distinguish between (1) inputs that reflect the assumptions market participants would use in pricing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs) and (2) inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing an asset or liability developed based on the best information available in the circumstances (unobservable inputs); and establishes a classification of fair value measurements for disclosure purposes. The hierarchy is summarized in the three broad levels listed below: Level 1 - quoted prices in active markets for identical assets and liabilities Level 2 - other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.) Level 3 - significant unobservable inputs (including the Company’s own assumptions in determining the fair value of assets and liabilities). In accordance with Accounting Standards Codification (“ASC”) 815, the Company’s debt derivative liabilities are measured at fair value on a recurring basis, and are level 3 measurements in the three-tier fair value hierarchy. There were no transfers between the levels of the fair value hierarchy during the three months ended March 31, 2017 and 2016. |
Fair value of financial instruments | Fair value of financial instruments The Company’s financial instruments consist primarily of cash, accounts payable and accrued expenses, and debt. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments. The following table summarizes fair value measurements by level at March 31, 2017 and December 31, 2016 measured at fair value on a recurring basis: March 31, 2017 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 260,771 $ 260,771 December 31, 2016 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 2,577,652 $ 2,577,652 |
Recently Issued Accounting Standards | Recently Issued Accounting Standards In February 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-06, “Plan Accounting: Defined Benefit Pension Plans (Topic 960); Defined Contribution Pension Plans (Topic 962); Health and Welfare Benefit Plans (Topic 965): Employee Benefit Plan Master Trust Reporting.” Among other things, the amendments require a plan’s interest in that master trust and any change in that interest to be presented in separate line items in the statement of net assets available for benefits and in the statement of changes in net assets available for benefits, respectively. The amendments also remove the requirement to disclose the percentage interest in the master trust for plans with divided interests and require that all plans disclose the dollar amount of their interest in each of those general types of investments. The amendments require all plans to disclose: (a) their master trust’s other asset and liability balances; and (b) the dollar amount of the plan’s interest in each of those balances. Lastly, the amendments eliminate redundant investment disclosures (e.g., those required by Topics 815 and 820) relating to 401(h) account assets. Effective for fiscal years beginning after December 15, 2018. Early adoption is permitted. The amendments should be applied retrospectively to each period for which financial statements are presented. The Company does not anticipate the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements. In February 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-05, “Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets.” The amendments clarify that a financial asset is within the scope of Subtopic 610-20 if it meets the definition of an in substance nonfinancial asset. The amendments also define the term in substance nonfinancial asset. The amendments clarify that nonfinancial assets within the scope of Subtopic 610-20 may include nonfinancial assets transferred within a legal entity to a counterparty. For example, a parent may transfer control of nonfinancial assets by transferring ownership interests in a consolidated subsidiary. A contract that includes the transfer of ownership interests in one or more consolidated subsidiaries is within the scope of Subtopic 610-20 if substantially all of the fair value of the assets that are promised to the counterparty in a contract is concentrated in nonfinancial assets. The amendments clarify that an entity should identify each distinct nonfinancial asset or in substance nonfinancial asset promised to a counterparty and derecognize each asset when a counterparty obtains control of it. Effective at the same time as the amendments in Update 2014-09, Revenue from Contracts with Customers (Topic 606). Therefore, public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the amendments in this Update to annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities should apply the amendments in this Update to annual reporting periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. All other entities may apply the guidance earlier as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities also may apply the guidance earlier as of annual reporting periods beginning after December 15, 2016, and interim reporting periods within annual reporting periods beginning one year after the annual reporting period in which the entity first applies the guidance. An entity is required to apply the amendments in this Update at the same time that it applies the amendments in Update 2014-09. The Company is currently evaluating the potential impact this standard may have on its financial position and results of operations. In January 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” These amendments eliminate Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. Effective for public business entities that are a SEC filers for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. ASU 2017-04 should be adopted on a prospective basis. The Company does not anticipate the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This new standard clarifies the definition of a business and provides a screen to determine when an integrated set of assets and activities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This new standard will be effective for the Company on January 1, 2018, however, early adoption is permitted with prospective application to any business development transaction. Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements. |
SIGNIFICANT ACCOUNTING POLICI19
SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Schedule of differences between reported amount and reporting currency denominated amount | March 31, 2017 December 31, 2016 Spot Euro: USD exchange rate $ 1.07 $ 1.05 Average Euro: USD exchange rate $ 1.06 $ 1.08–1.12 |
Schedule of fair value measurements recurring and nonrecurring | March 31, 2017 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 260,771 $ 260,771 December 31, 2016 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 2,577,652 $ 2,577,652 |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
Schedule of property and equipment | March 31, December 31, 2017 2016 Furniture $ 5,915 $ 5,915 Computers 18,886 18,886 24,801 24,801 Accumulated Depreciation (18,639 ) (17,593 ) Foreign currency translation effect (2,358 ) (2,439 ) Property and equipment, net $ 3,804 $ 4,769 |
NOTES PAYABLE (Tables)
NOTES PAYABLE (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Debt Instrument [Line Items] | |
Schedule of note payable | March 31, December 31, 2017 2016 Promissory Notes - December 2016 $ 51,000 $ 51,000 Promissory Notes - January 2017 10,000 - Less current portion of notes payable 61,000 51,000 Long-term notes payable $ - $ - |
Notes Payable - Related Parties | |
Debt Instrument [Line Items] | |
Schedule of note payable | March 31, December 31, 2017 2016 Promissory Notes $ 39,590 $ 38,850 Less current portion of notes payable 39,590 38,850 Long-term notes payable $ - $ - |
CONVERTIBLE NOTES PAYABLE (Tabl
CONVERTIBLE NOTES PAYABLE (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Convertible Notes Payable [Abstract] | |
Schedule of convertible note payable | March 31, December31, 2017 2016 Convertible Note - December 2015 $ 350,000 $ 350,000 Convertible Note - February 2016 - 30,000 Convertible Note - March 2016 250,000 250,000 Convertible Notes - May 2016 62,500 75,000 Convertible Note - June 2016 15,000 15,000 Convertible Notes - September 2016 176,510 201,511 Convertible Notes -October 2016 130,748 148,798 Convertible Notes - November 2016 25,000 25,000 Convertible Notes - December 2016 75,000 75,000 Convertible Notes - March 2017 168,500 - 1,253,258 1,170,309 Less debt discount and debt issuance cost (267,403 ) (414,118 ) 985,855 756,191 Less current portion of convertible notes payable 985,855 756,191 Long-term convertible notes payable $ - $ - |
Schedule of outstanding and exercisable warrants | Warrants Outstanding Warrants Exercisable Number of Shares Weighted Average Remaining Contractual life Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price 3/28/2016 250,000 3.99 $ 0.40 250,000 $ 0.40 9/12/2016 75,000 2.42 0.0211 75,000 0.0211 9/12/2016 50,755 2.42 0.0211 50,755 0.0211 9/21/2016 75,000 2.45 0.0211 75,000 0.0211 1/30/2017 2,000,000 2.84 0.2500 2,000,000 0.2500 2/21/2017 1,000,000 0.90 0.0200 - - 2/28/2017 124,000 1.92 0.0200 124,000 0.0200 2/28/2017 12,500 1.92 0.0200 12,500 0.0200 3,587,255 2,587,255 |
Schedule of warrants activity | Warrants Outstanding Weighted Average Shares Exercise Price Balances as of December 31, 2016 450,755 $ 0.23 Granted 3,136,500 0.17 Exercised - - Forfeited/canceled - - Balances as of March 31, 2017 3,587,255 $ 0.17 |
DERIVATIVE LIABILITIES (Tables)
DERIVATIVE LIABILITIES (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Derivative Liability [Abstract] | |
Schedule of derivative liabilities | Three Months Ended Year Ended March 31, 2017 December 31, 2016 Expected term 0.08 - 3.99 years 0.10 - 5.00 years Expected average volatility 113% - 151% 98% - 169% Expected dividend yield - - Risk-free interest rate 0.67%-1.72% 0.36% - 1.93% |
Schedule of loss on derivative liability | Fair Value Measurements Using Significant Observable Inputs (Level 3) Balance - December 31, 2016 $ 2,577,652 Addition of new derivative liabilities upon issuance of convertible notes as debt discounts 24,631 Addition of new derivatives liabilities recognized as issuance of warrants as stock based compensation expense 17,737 Reduction of derivatives liabilities from conversion of convertible note to common shares (81,943 ) Gain on change in fair value of the derivative liabilities (2,277,306 ) Balance – March 31, 2017 $ 260,771 |
Schedule of fair value of the option liability at each measurement date | Three Months Ended March 31, 2017 2016 Day one loss due to derivative liabilities on convertible notes and warrants $ - $ 284,380 (Gain) Loss on change in fair value of the derivative liabilities (2,277,306 ) 891,770 (Gain) Loss on change in the fair value of derivative liabilities $ (2,277,306 ) $ 1,176,150 |
CONCENTRATIONS (Tables)
CONCENTRATIONS (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Risks and Uncertainties [Abstract] | |
Schedule of information as customer that accounted to the Company's revenues | Three Months Ended Three Months Ended Customer March 31, 2017 March 31, 2016 EU PWN 59 % 100 % US NRECA 41 % - |
INCENTIVE STOCK PLANS (Tables)
INCENTIVE STOCK PLANS (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Schedule of stock options outstanding | Options Outstanding Weighted- Fair Value Number of Average on Grant Intrinsic Shares Exercise Price Date Value Balances as of December 31, 2016 8,173,686 $ 0.0587 $ 71,630 $ 2,997 Granted - - - - Exercised - - - - Forfeited/canceled - - - - Balances as of March 31, 2017 8,173,686 $ 0.0587 $ 71,630 $ - |
Schedule of weighted-average assumptions | Year Ended December 31, 2015 Expected term 5 years Expected average volatility 95 % Expected dividend yield - Risk-free interest rate 1.67 % Expected annual forfeiture rate - |
Schedule of outstanding and exercisable stock options | Options Outstanding Options Exercisable Number of Shares Weighted Average Remaining Contractual life (in years) Weighted Average Number of Shares Weighted Average 8,173,686 3.73 $ 0.0587 2,724,562 $ 0.0489 |
ORGANIZATION AND BUSINESS (Deta
ORGANIZATION AND BUSINESS (Detail Textuals) - USD ($) | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Operating losses | $ (344,018) | $ (460,799) | |
Accumulated deficit | (3,497,809) | $ (5,255,277) | |
Working capital | $ 2,126,729 |
SIGNIFICANT ACCOUNTING POLICI27
SIGNIFICANT ACCOUNTING POLICIES (Details) | Mar. 31, 2017 | Dec. 31, 2016 |
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Spot Euro: USD exchange rate | 1.07 | 1.05 |
Average Euro: USD exchange rate | 1.06 | |
Minimum | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Average Euro: USD exchange rate | 1.08 | |
Maximum | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Average Euro: USD exchange rate | 1.12 |
SIGNIFICANT ACCOUNTING POLICI28
SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($) | Mar. 31, 2017 | Dec. 31, 2016 |
Assets | ||
Assets | ||
Liabilities | ||
Derivative liabilities | 260,771 | 2,577,652 |
Level 1 | ||
Assets | ||
Assets | ||
Liabilities | ||
Derivative liabilities | ||
Level 2 | ||
Assets | ||
Assets | ||
Liabilities | ||
Derivative liabilities | ||
Level 3 | ||
Assets | ||
Assets | ||
Liabilities | ||
Derivative liabilities | $ 260,771 | $ 2,577,652 |
SIGNIFICANT ACCOUNTING POLICI29
SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) | 3 Months Ended | ||||
Mar. 31, 2017USD ($) | Mar. 31, 2016USD ($) | Mar. 31, 2017EUR (€) | Dec. 31, 2016USD ($) | Dec. 31, 2016EUR (€) | |
Accounting Polices [Line Items] | |||||
Share-based Compensation | $ 28,184 | $ 50,842 | |||
U.S. bank | |||||
Accounting Polices [Line Items] | |||||
Cash held in accounts | 119,010 | $ 9,971 | |||
Netherlands | |||||
Accounting Polices [Line Items] | |||||
Cash held in accounts | $ 1,856 | € 1,735 | $ 3,203 | € 3,050 |
PROPERTY AND EQUIPMENT (Details
PROPERTY AND EQUIPMENT (Details) - USD ($) | Mar. 31, 2017 | Dec. 31, 2016 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, Gross | $ 24,801 | $ 24,801 |
Accumulated Depreciation | (18,639) | (17,593) |
Foreign currency translation effect | (2,358) | (2,439) |
Property and equipment, net | 3,804 | 4,769 |
Furniture | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, Gross | 5,915 | 5,915 |
Computers | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, Gross | $ 18,886 | $ 18,886 |
PROPERTY AND EQUIPMENT (Detail
PROPERTY AND EQUIPMENT (Detail Textuals) - USD ($) | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Property, Plant and Equipment [Abstract] | ||
Depreciation expense | $ 1,047 | $ 1,386 |
NOTES PAYABLE (Details)
NOTES PAYABLE (Details) - USD ($) | Mar. 31, 2017 | Dec. 31, 2016 |
Debt Instrument [Line Items] | ||
Less current portion of notes payable | $ 61,000 | $ 51,000 |
Long-term notes payable | ||
Notes Payable - Related Parties | ||
Debt Instrument [Line Items] | ||
Promissory Notes | 39,590 | 38,850 |
Less current portion of notes payable | 39,590 | 38,850 |
Long-term notes payable | ||
Promissory Notes - December 2016 | ||
Debt Instrument [Line Items] | ||
Promissory Notes | 51,000 | 51,000 |
Promissory Notes - January 2017 | ||
Debt Instrument [Line Items] | ||
Promissory Notes | $ 10,000 |
NOTES PAYABLE (Detail Textuals)
NOTES PAYABLE (Detail Textuals) | 1 Months Ended | 3 Months Ended | |||||||||||
Dec. 31, 2016USD ($) | Dec. 31, 2016EUR (€) | Mar. 31, 2017USD ($) | Mar. 31, 2016USD ($) | Jan. 26, 2017USD ($) | Dec. 30, 2016USD ($) | Sep. 12, 2016shares | Aug. 29, 2016USD ($) | Aug. 29, 2016EUR (€) | Jun. 30, 2016USD ($) | Jun. 30, 2016EUR (€) | Jun. 29, 2016USD ($) | Jun. 29, 2016EUR (€) | |
Debt Instrument [Line Items] | |||||||||||||
Accrued interest | $ 28 | $ 2,894 | |||||||||||
Amortization of debt discount and debt issue cost | 189,845 | $ 10,479 | |||||||||||
Loss on extinguishment of debt | 69,389 | ||||||||||||
Promissory Note | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Convertible debt, interest rate | 20.00% | 20.00% | |||||||||||
Principle amount of debt | $ 10,000 | $ 51,000 | |||||||||||
Number of shares called by warrants | shares | 50,755 | ||||||||||||
Promissory Note | Notes Payable - Related Parties | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Accrued interest | 2,046 | $ 2,866 | |||||||||||
Convertible debt, interest rate | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | |||||||
Principle amount of debt | $ 37,450 | € 35,000 | $ 10,700 | € 10,000 | $ 10,700 | € 10,000 | |||||||
Amount of note payable repaid | $ 18,900 | € 18,000 |
CONVERTIBLE NOTES PAYABLE (Deta
CONVERTIBLE NOTES PAYABLE (Details) - USD ($) | Mar. 31, 2017 | Dec. 31, 2016 |
Debt Instrument [Line Items] | ||
Less current portion of convertible note payable | $ (985,855) | $ (756,191) |
Convertible Note | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 1,253,258 | 1,170,309 |
Less debt discount and debt issuance cost | (267,403) | (414,118) |
Total | 985,855 | 756,191 |
Less current portion of convertible note payable | 985,855 | 756,191 |
Long-term convertible note payable | ||
Convertible Note | December 2015 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 350,000 | 350,000 |
Convertible Note | February 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 30,000 | |
Convertible Note | March 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 250,000 | 250,000 |
Convertible Note | May 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 62,500 | 75,000 |
Convertible Note | June 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 15,000 | 15,000 |
Convertible Note | September 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 176,510 | 201,511 |
Convertible Note | October 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 130,748 | 148,798 |
Convertible Note | November 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 25,000 | 25,000 |
Convertible Note | December 2016 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | 75,000 | 75,000 |
Convertible Note | March 2017 | ||
Debt Instrument [Line Items] | ||
Convertible notes payable | $ 168,500 |
CONVERTIBLE NOTES PAYABLE (De35
CONVERTIBLE NOTES PAYABLE (Details 1) - $ / shares | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
Class of Warrant or Right [Line Items] | ||
Warrants Outstanding, Number Of Shares | 3,587,255 | 450,755 |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.17 | $ 0.23 |
Warrants Exercisable, Number of Shares | 2,587,255 | |
Weighted Average Exercise Price $ 0.40 | 3/28/2016 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Mar. 28, 2016 | |
Warrants Outstanding, Number Of Shares | 250,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 3 years 11 months 27 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.4 | |
Warrants Exercisable, Number of Shares | 250,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.4 | |
Weighted Average Exercise Price $ 0.0211 | 9/12/2016 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Sep. 12, 2016 | |
Warrants Outstanding, Number Of Shares | 75,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 2 years 5 months 1 day | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0211 | |
Warrants Exercisable, Number of Shares | 75,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0211 | |
Weighted Average Exercise Price $ 0.0211 | 9/12/2016 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Sep. 12, 2016 | |
Warrants Outstanding, Number Of Shares | 50,755 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 2 years 5 months 1 day | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0211 | |
Warrants Exercisable, Number of Shares | 50,755 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0211 | |
Weighted Average Exercise Price $ 0.0211 | 9/21/2016 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Sep. 21, 2016 | |
Warrants Outstanding, Number Of Shares | 75,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 2 years 5 months 12 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0211 | |
Warrants Exercisable, Number of Shares | 75,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0211 | |
Weighted Average Exercise Price $ 0.2500 | 1/30/2017 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Jan. 30, 2017 | |
Warrants Outstanding, Number Of Shares | 2,000,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 2 years 10 months 2 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.2500 | |
Warrants Exercisable, Number of Shares | 2,000,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.2500 | |
Weighted Average Exercise Price $ 0.0200 | 2/21/2017 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Feb. 21, 2017 | |
Warrants Outstanding, Number Of Shares | 1,000,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 10 months 24 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0200 | |
Warrants Exercisable, Number of Shares | ||
Warrants Exercisable, Weighted Average Exercise Price | ||
Weighted Average Exercise Price $ 0.0200 | 2/28/2017 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Feb. 28, 2017 | |
Warrants Outstanding, Number Of Shares | 124,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 1 year 11 months 1 day | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0200 | |
Warrants Exercisable, Number of Shares | 124,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0200 | |
Weighted Average Exercise Price $ 0.0200 | 2/28/2017 | ||
Class of Warrant or Right [Line Items] | ||
Issue Date | Feb. 28, 2017 | |
Warrants Outstanding, Number Of Shares | 12,500 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 1 year 11 months 1 day | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0200 | |
Warrants Exercisable, Number of Shares | 12,500 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0200 |
CONVERTIBLE NOTES PAYABLE (De36
CONVERTIBLE NOTES PAYABLE (Details 2) | 3 Months Ended |
Mar. 31, 2017$ / sharesshares | |
Number of Shares | |
Balances as of December 31, 2016 | shares | 450,755 |
Granted | shares | 3,136,500 |
Exercised | shares | |
Forfeited/canceled/expired | shares | |
Balances as of March 31, 2017 | shares | 3,587,255 |
Weighted- Average Exercise Price | |
Balances as of December 31, 2016 | $ / shares | $ 0.23 |
Granted | $ / shares | 0.17 |
Exercised | $ / shares | |
Forfeited/canceled/expired | $ / shares | |
Balances as of March 31, 2017 | $ / shares | $ 0.17 |
CONVERTIBLE NOTES PAYABLE (De37
CONVERTIBLE NOTES PAYABLE (Detail Textuals) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||
Jul. 22, 2016USD ($)$ / sharesshares | Dec. 21, 2015USD ($)Day | Mar. 31, 2017USD ($)$ / sharesshares | Mar. 31, 2016USD ($) | Dec. 31, 2016USD ($)shares | Jan. 26, 2017USD ($) | Dec. 30, 2016USD ($) | Sep. 12, 2016shares | |
Debt Instrument [Line Items] | ||||||||
Amortization of debt discount and debt issue cost | $ 189,845 | $ 10,479 | ||||||
Gain on extinguishment of debt | 69,389 | |||||||
Derivative liabilities | 260,771 | $ 2,577,652 | ||||||
Derivative liability recognized as debt discount | 24,631 | 263,879 | ||||||
Day one loss due to derivative on convertible note | (284,380) | |||||||
Change in fair value of derivative liability | 2,277,306 | (891,770) | ||||||
Promissory Note | ||||||||
Debt Instrument [Line Items] | ||||||||
Principle amount of debt | $ 10,000 | $ 51,000 | ||||||
Number of shares called by warrants | shares | 50,755 | |||||||
Percentage of promissory note | 20.00% | 20.00% | ||||||
Convertible notes payable | ||||||||
Debt Instrument [Line Items] | ||||||||
Principle amount of debt | $ 820,308 | |||||||
Number of shares called by warrants | shares | 450,755 | |||||||
Debt conversion, description | Conversion prices are typically based on the discounted (20% - 25% discount) lowest trading prices of the Company's shares during various periods prior to conversion. Certain notes are subject to adjustment to not convert in a value band, not lower than $4,000,000 to $6,000,000 or higher than $12,000,000 to $18,000,000, divided by the total number of shares of common stock outstanding immediately prior to the conversion date. | |||||||
Gain on extinguishment of debt | $ 56,534 | |||||||
Amount of convertible note converted | $ 150,000 | 85,550 | ||||||
Market trading price per share | shares | 941,620 | |||||||
Conversion price | $ / shares | $ 0.27 | |||||||
Derivative liabilities | $ 160,771 | |||||||
Amount of accrued interest | $ 6,023 | |||||||
Number of shares issued upon conversion of debt | shares | 4,642,725 | |||||||
Convertible notes payable | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of promissory note | 8.00% | |||||||
Term of debt instrument | 6 months | |||||||
Convertible notes payable | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of promissory note | 20.00% | |||||||
Term of debt instrument | 18 months | |||||||
Convertible notes payable | Promissory Note | EMA Financial, LLC | ||||||||
Debt Instrument [Line Items] | ||||||||
Principle amount of debt | $ 168,500 | |||||||
Percentage of promissory note | 10.00% | |||||||
Term of debt instrument | 1 year | |||||||
Amount of convertible note converted | $ 85,550 | |||||||
Conversion price | $ / shares | $ 0.04 | |||||||
Financing costs paid | $ 18,500 | |||||||
Derivative liabilities | 260,771 | $ 2,577,652 | ||||||
Derivative liability recognized as debt discount | 24,631 | 263,879 | ||||||
Day one loss due to derivative on convertible note | $ 0 | $ 284,380 | ||||||
Description of debt conversion default as per Section 1.9 | (i) the closing sale price of Common Stock on the Principal Market on the Trading Day immediately preceding the Closing Date, and (ii) 60% of either the lowest sale price for the Common Stock on the Principal Market during the twenty (20) consecutive Trading Days immediately preceding the Conversion Date or the closing bid price, whichever is lower, provided, however, if the Company's share price at any time loses the bid (ex: 0.0001 on the ask with zero market makers on the bid on level 2), then the Conversion Price may, in the Purchaser's sole and absolute discretion, be reduced to a fixed conversion price of 0.00001 (if lower than the conversion price otherwise), and provided, that if on the date of delivery of the Conversion Shares to the Purchaser, or any date thereafter while Conversion Shares are held by the Purchaser, the closing bid price per share of Common Stock on the Principal Market on the Trading Day on which the Common Shares are traded is less than the sale price per share of Common Stock on the Principal Market on the Trading Day used to calculate the Conversion Price hereunder, then such Conversion Price shall be automatically reduced such that the Conversion Price shall be recalculated using the new low closing bid price ("Adjusted Conversion Price") and shall replace the Conversion Price above, and Purchaser shall be issued a number of additional shares such that the aggregate number of shares Purchaser receives is based upon the Adjusted Conversion Price, and provided, further, that the Conversion Price shall be subject to further adjustment in Section 1.2(b) of the Note. Purchaser does not have the right to convert the Note, to the extent that it would beneficially own in excess of 4.9% of the Company's outstanding common stock. | |||||||
Description of debt conversion default as per Section 3.9 | (i) the closing sale price of the Common Stock on the Principal Market on the Trading Day immediately preceding the Closing Date; (ii) 60% of either the lowest sale price or the closing bid price, whichever is lower for the Common Stock on the Principal Market during any Trading Day in which the Event of Default has not been cured. If such Common Stock is not traded on the OTCBB, OTCQB, NASDAQ or NYSE, then such sale price shall be the sale price of such security on the principal securities exchange or trading market where such security is listed or traded or, if no sale price of such security is available in any of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the "pink sheets" by the National Quotation Bureau, Inc. If such sale price cannot be calculated for such security on such date in the manner provided above, such price shall be the fair market value as mutually determined by the Company and the Purchaser. If the Company's Common stock is chilled for deposit at DTC, becomes chilled at any point while this Note remains outstanding or deposit or other additional fees are payable due to a Yield Sign, Stop Sign or other trading restrictions, or if the closing sale price at any time falls below $0.01 (as appropriately and equitably adjusted for stock splits, stock dividends, stock contributions and similar events), then such 60% figure specified above shall be reduced to 45%. In the event that the shares of the Company's Common Stock are not deliverable via DWAC following the conversion of any amount hereunder, an additional 5% discount will be attributed to the Conversion Price. Additionally, the Company acknowledges that it will take all reasonable steps necessary or appropriate, including providing a board of directors resolution authorizing the issuance of common stock to Purchaser. | |||||||
Amount of accrued interest | $ 6,023 | |||||||
Amount of gain recognized on note conversion | $ 69,389 | |||||||
Valuation technique used for fair value measurement | Black Scholes valuation model | |||||||
Number of shares issued upon conversion of debt | shares | 4,642,725 | |||||||
Convertible notes payable | Share Exchange Agreement | Promissory Note | Insight Innovators, B.V. | Investor | ||||||||
Debt Instrument [Line Items] | ||||||||
Principle amount of debt | $ 500,000 | |||||||
Percentage of promissory note | 10.00% | |||||||
Assumed accrued interest | $ 3,838 | |||||||
Conversion price percentage | 75.00% | |||||||
Trading days | Day | 10 | |||||||
Convertible notes conversion, description | (i) lower than $4,000,000 divided by the total number of shares of Common Stock outstanding immediately prior to the conversion date; or (ii) greater than $12,000,000 divided by the total number of shares of common stock outstanding immediately prior to the conversion date. |
CONVERTIBLE NOTES PAYABLE (De38
CONVERTIBLE NOTES PAYABLE (Detail Textuals 1) | Sep. 12, 2016USD ($)Dayshares | Feb. 28, 2017$ / sharesshares | Feb. 21, 2017$ / sharesshares | Jan. 30, 2017$ / sharesshares | Sep. 21, 2016USD ($)Dayshares | Mar. 28, 2016USD ($)$ / sharesshares | Mar. 31, 2017USD ($)$ / sharesshares | Mar. 31, 2016USD ($) | Dec. 31, 2016USD ($)$ / sharesshares |
Debt Instrument [Line Items] | |||||||||
Proceeds from issuance of convertible note payable | $ | $ 135,846 | $ 250,000 | |||||||
Exercise price of warrants | $ / shares | $ 0.17 | $ 0.23 | |||||||
Number of warrants issued | 3,136,500 | ||||||||
Convertible Note - September 12, 2016 | |||||||||
Debt Instrument [Line Items] | |||||||||
Principle amount of debt | $ | $ 150,000 | ||||||||
Number of shares called by warrants | 75,000 | ||||||||
Number of warrants exercisable into common stock | 75,000 | ||||||||
Convertible Note | |||||||||
Debt Instrument [Line Items] | |||||||||
Principle amount of debt | $ | $ 820,308 | ||||||||
Number of shares called by warrants | 450,755 | ||||||||
Number of warrants issued | 3,136,500 | ||||||||
Convertible Note | March 2016 | |||||||||
Debt Instrument [Line Items] | |||||||||
Principle amount of debt | $ | $ 250,000 | ||||||||
Number of shares called by warrants | 250,000 | ||||||||
Number of warrants exercisable into common stock | 250,000 | ||||||||
Term of warrants (in years) | 5 years | ||||||||
Exercise price of warrants | $ / shares | $ 0.40 | ||||||||
Convertible Note | Convertible Note - September 12, 2016 | |||||||||
Debt Instrument [Line Items] | |||||||||
Principle amount of debt | $ | $ 101,511 | ||||||||
Number of shares called by warrants | 50,755 | ||||||||
Number of warrants exercisable into common stock | 50,755 | ||||||||
Term of warrants (in years) | 1 year | ||||||||
Percentage of lowest trading price | 120.00% | ||||||||
Number of trading day prior to exercise date | Day | 20 | ||||||||
Convertible Note | Convertible Note - September 12, 2016 | |||||||||
Debt Instrument [Line Items] | |||||||||
Principle amount of debt | $ | $ 150,000 | ||||||||
Number of shares called by warrants | 75,000 | ||||||||
Number of warrants exercisable into common stock | 75,000 | ||||||||
Term of warrants (in years) | 1 year | ||||||||
Percentage of lowest trading price | 120.00% | ||||||||
Number of trading day prior to exercise date | Day | 20 | ||||||||
Convertible Note | Convertible Note - September 21, 2016 | |||||||||
Debt Instrument [Line Items] | |||||||||
Principle amount of debt | $ | $ 150,000 | ||||||||
Number of shares called by warrants | 75,000 | ||||||||
Number of warrants exercisable into common stock | 75,000 | ||||||||
Term of warrants (in years) | 1 year | ||||||||
Percentage of lowest trading price | 120.00% | ||||||||
Number of trading day prior to exercise date | Day | 20 | ||||||||
Convertible Note | Convertible Note - January 30, 2017 | |||||||||
Debt Instrument [Line Items] | |||||||||
Number of shares called by warrants | 2,000,000 | ||||||||
Number of warrants exercisable into common stock | 2,000,000 | ||||||||
Term of warrants (in years) | 3 years | ||||||||
Exercise price of warrants | $ / shares | $ 0.25 | ||||||||
Convertible Note | Convertible Note - February 21, 2017 | |||||||||
Debt Instrument [Line Items] | |||||||||
Number of shares called by warrants | 1,000,000 | ||||||||
Number of warrants exercisable into common stock | 1,000,000 | ||||||||
Term of warrants (in years) | 3 years | ||||||||
Exercise price of warrants | $ / shares | $ 0.02 | ||||||||
Convertible Note | Convertible Note - February 28, 2017 | |||||||||
Debt Instrument [Line Items] | |||||||||
Number of shares called by warrants | 136,500 | ||||||||
Number of warrants exercisable into common stock | 136,500 | ||||||||
Term of warrants (in years) | 3 years | ||||||||
Exercise price of warrants | $ / shares | $ 0.02 |
DERIVATIVE LIABILITIES (Details
DERIVATIVE LIABILITIES (Details) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2017 | Dec. 31, 2016 | |
Derivative Liabilities [Line Items] | ||
Expected dividend yield | ||
Minimum | ||
Derivative Liabilities [Line Items] | ||
Expected term | 29 days | 1 month 6 days |
Expected average volatility | 113.00% | 98.00% |
Risk-free interest rate | 0.67% | 0.36% |
Maximum | ||
Derivative Liabilities [Line Items] | ||
Expected term | 3 years 11 months 27 days | 5 years |
Expected average volatility | 151.00% | 169.00% |
Risk-free interest rate | 1.72% | 1.93% |
DERIVATIVE LIABILITIES (Detai40
DERIVATIVE LIABILITIES (Details 1) | 3 Months Ended |
Mar. 31, 2017USD ($) | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance - December 31, 2016 | $ 2,577,652 |
Addition of new derivative liabilities upon issuance of convertible notes as debt discounts | 24,631 |
Addition of new derivatives liabilities recognized as issuance of warrants as stock based compensation expense | 17,737 |
Reduction of derivatives liabilities from conversion of convertible note to common shares | (81,943) |
Gain on change in fair value of the derivative liabilities | (2,277,306) |
Balance - March 31, 2017 | $ 260,771 |
DERIVATIVE LIABILITIES (Detai41
DERIVATIVE LIABILITIES (Details 2) - USD ($) | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Derivative Liability [Abstract] | ||
Day one loss due to derivative liabilities on convertible notes and warrants | $ 284,380 | |
(Gain) Loss on change in fair value of the derivative liabilities | (2,277,306) | 891,770 |
(Gain) Loss on change in the fair value of derivative liabilities | $ (2,277,306) | $ 1,176,150 |
RELATED PARTY CONSIDERATIONS (D
RELATED PARTY CONSIDERATIONS (Detail Textuals) | Jul. 01, 2014EUR (€) | Mar. 31, 2017USD ($) | Mar. 31, 2017EUR (€) | Mar. 31, 2016USD ($) | Dec. 31, 2016USD ($) |
Related Party Transaction [Line Items] | |||||
Management fees | $ 122,448 | $ 124,552 | |||
Management fees payable - related parties | 390,459 | $ 296,816 | |||
Accrued interest - related parties | 20,835 | $ 9,172 | |||
Insight | |||||
Related Party Transaction [Line Items] | |||||
Payments for rent per month | € 7,500 | $ 1,590 | € 1,500 |
CONCENTRATIONS (Details)
CONCENTRATIONS (Details) - Revenue - Customer concentration risk | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
EU | PWN | ||
Concentration Risk [Line Items] | ||
Concentration risk percentage | 59.00% | 100.00% |
US | NRECA | ||
Concentration Risk [Line Items] | ||
Concentration risk percentage | 41.00% |
CONCENTRATIONS (Detail Textuals
CONCENTRATIONS (Detail Textuals) - USD ($) | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Concentration Risk [Line Items] | ||
Revenues | $ 18,233 | $ 1,732 |
Insight Innovators, B.V. | ||
Concentration Risk [Line Items] | ||
Revenues | $ 10,733 |
STOCKHOLDERS' DEFICIT (Detail T
STOCKHOLDERS' DEFICIT (Detail Textuals) - $ / shares | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
Stockholders Equity Note [Line Items] | ||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Number of common stock shares issued upon conversion | 3,579,256 | |
Series A convertible preferred stock | ||
Stockholders Equity Note [Line Items] | ||
Preferred stock, shares authorized | 808,000 | 808,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, stated value per share (in dollars per share) | $ 1 | $ 1 |
Preferred stock, voting rights description | the shares have no voting rights, provided, however, that for so long as any shares are outstanding, we many not, without the affirmative vote of at least 51% of the then outstanding shares of the Series A Preferred, (a) alter or change adversely the powers, preferences or rights given to the Series A Preferred or alter or amend the Certificate of Designation, (b) authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation (as defined) senior to, or otherwise in pari passu with, the Series A Preferred, (c) amend our articles of incorporation or other charter documents in any manner that adversely affects any rights of the holders, (d) increase the number of authorized shares of Series A Preferred, or (e) enter into any agreement with respect to any of the foregoing. | |
Conversion price | $ 0.1778 | |
Conversion price post stock split | $ 0.0296 | |
Number of shares converted | 105,946 | |
Number of common stock shares issued upon conversion | 3,579,256 | |
Preferred stock, shares issued | 94,333 | 200,279 |
Preferred stock, shares outstanding | 94,333 | 200,279 |
STOCKHOLDERS' DEFICIT (Detail46
STOCKHOLDERS' DEFICIT (Detail Textuals 1) - USD ($) | 1 Months Ended | 3 Months Ended | |
Jul. 22, 2016 | Mar. 31, 2017 | Dec. 31, 2016 | |
Stockholders Equity Note [Line Items] | |||
Common stock, shares authorized | 500,000,000 | 500,000,000 | |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | |
Common stock, voting rights | one vote | ||
Aggregate shares issued during period | 9,586,981 | ||
Number of shares issued | 1,365,000 | ||
Value of shares issued | $ 27,300 | ||
Number of common stock shares issued upon conversion | 3,579,256 | ||
Common stock, shares issued | 107,044,378 | 97,457,397 | |
Common stock, shares outstanding | 107,044,378 | 97,457,397 | |
Series A convertible preferred stock | |||
Stockholders Equity Note [Line Items] | |||
Number of common stock shares issued upon conversion | 3,579,256 | ||
Number of shares converted | 105,946 | ||
Convertible notes payable | |||
Stockholders Equity Note [Line Items] | |||
Number of shares issued upon conversion of debt | 4,642,725 | ||
Amount of convertible note converted | $ 150,000 | $ 85,550 | |
Amount of accrued interest | 6,023 | ||
Value of common stock in a conversion of Convertible Notes | $ 104,128 |
INCENTIVE STOCK PLANS (Details)
INCENTIVE STOCK PLANS (Details) - Stock Option - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2017 | Dec. 31, 2015 | |
Options Outstanding, Number of Shares | ||
Balances as of December 31, 2016 | 8,173,686 | |
Granted | 8,173,686 | |
Exercised | ||
Forfeited/canceled | ||
Balances as of March 31, 2017 | 8,173,686 | |
Options Outstanding, Weighted- Average Exercise Price | ||
Balances as of December 31, 2016 | $ 0.0587 | |
Granted | ||
Exercised | ||
Forfeited/canceled | ||
Balances as of March 31, 2017 | $ 0.0587 | |
Options Outstanding, Fair Value on Grant Date | ||
Balances as of December 31, 2016 | $ 71,630 | |
Granted | ||
Exercised | ||
Forfeited/canceled | ||
Balances as of March 31, 2017 | 71,630 | |
Intrinsic Value | ||
Balances as of December 31, 2016 | 2,997 | |
Granted | ||
Exercised | ||
Forfeited/canceled | ||
Balances as of March 31, 2017 |
INCENTIVE STOCK PLANS (Details
INCENTIVE STOCK PLANS (Details 1) - Stock Option | 3 Months Ended |
Mar. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Expected term | 5 years |
Expected average volatility | 95.00% |
Expected dividend yield | |
Risk-free interest rate | 1.67% |
Expected annual forfeiture rate |
INCENTIVE STOCK PLANS (Detail49
INCENTIVE STOCK PLANS (Details 2) - Stock Option - $ / shares | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Options Outstanding, Number of Shares | 8,173,686 | 8,173,686 |
Options Outstanding, Weighted Average Remaining Contractual life (in years) | 3 years 8 months 23 days | |
Options Outstanding, Weighted Average Exercise Price | $ 0.0587 | $ 0.0587 |
Options Exercisable, Number of Shares | 2,724,562 | |
Options Exercisable, Weighted Average Exercise Price | $ 0.0489 |
INCENTIVE STOCK PLANS (Detail T
INCENTIVE STOCK PLANS (Detail Textuals) - Stock Option - USD ($) | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of stock options granted | 8,173,686 | |||
Weighted average value granted options | $ 0.0587 | $ 0.0587 | ||
Weighted-average remaining contract term of outstanding options | 3 years 8 months 23 days | |||
Term of options granted | 5 years | |||
Compensation cost expected to be recognized for unvested options | $ 22,568 | |||
Aggregate intrinsic value of options outstanding | $ 2,997 | |||
Share based compensation | $ 4,910 | $ 10,842 | ||
Number of options exercisable | 2,724,562 | |||
Intrinsic value of options exercisable | ||||
Number of options outstanding, expected to vest | 5,449,124 | |||
Aggregate intrinsic value of options outstanding, expected to vest | ||||
1/3 shares | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Weighted average value granted options | $ 0.04893 | |||
1/3 shares | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Weighted average value granted options | 0.05873 | |||
1/3 shares | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Weighted average value granted options | $ 0.06852 | |||
Messrs. Verweij, van Wijk and de Vrie | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Aggregate intrinsic value of options outstanding | $ 71,630 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Detail Textuals) | Jul. 01, 2014EUR (€) | Mar. 31, 2017USD ($)ft² | Mar. 31, 2017EUR (€) | Mar. 31, 2016USD ($) | Dec. 31, 2016USD ($) |
Commitments And Contingencies [Line Items] | |||||
Total rent expenses | $ 4,770 | $ 4,995 | |||
Rent payable | $ 23,305 | $ 17,152 | |||
Insight | |||||
Commitments And Contingencies [Line Items] | |||||
Leases space in Netherlands from related party | ft² | 4,000 | ||||
Payments for rent per month | € 7,500 | $ 1,590 | € 1,500 |
COMMITMENTS AND CONTINGENCIES52
COMMITMENTS AND CONTINGENCIES (Detail Textuals 1) - 1 months ended Dec. 21, 2015 - Employment Agreement | USD ($)CustomerAnniversary$ / sharesshares | EUR (€)CustomerAnniversaryshares |
Arend D. Verweij | ||
Commitments And Contingencies [Line Items] | ||
Term of agreement | 2 years | 2 years |
Renewable period of agreement | 1 year | 1 year |
Notice period prior expiration | 30 days | 30 days |
Annual salary | $ | $ 180,000 | |
Increase in annual salary | $ | $ 252,000 | |
Number of customers have a minimum of 500 users of software system | Customer | 3 | 3 |
Performance bonus up to percentage of base salary | 100.00% | 100.00% |
Number of stock options granted | shares | 3,065,130 | 3,065,130 |
Vesting anniversaries of stock options | Anniversary | 3 | 3 |
Entitled period of paid vacation | Five weeks | Five weeks |
Monthly health insurance allowance | $ | $ 1,500 | |
Terms of employment agreement termination | (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. | (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. |
Arend D. Verweij | Year 1 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | $ 0.04893 | |
Arend D. Verweij | Year 2 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | 0.05873 | |
Arend D. Verweij | Year 3 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | $ 0.06852 | |
Geurt van Wijk | ||
Commitments And Contingencies [Line Items] | ||
Term of agreement | 2 years | 2 years |
Renewable period of agreement | 1 year | 1 year |
Notice period prior expiration | 30 days | 30 days |
Annual salary | € | € 120,000 | |
Increase in annual salary | € | € 150,000 | |
Number of customers have a minimum of 500 users of software system | Customer | 3 | 3 |
Performance bonus up to percentage of base salary | 75.00% | 75.00% |
Number of stock options granted | shares | 2,554,278 | 2,554,278 |
Vesting anniversaries of stock options | Anniversary | 3 | 3 |
Entitled period of paid vacation | Five weeks | Five weeks |
Monthly vehicle allowance limited upto annual base salary EURO 150,000 | € | € 1,350 | |
Terms of employment agreement termination | (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. | (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. |
Geurt van Wijk | Year 1 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | $ 0.04893 | |
Geurt van Wijk | Year 2 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | 0.05873 | |
Geurt van Wijk | Year 3 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | $ 0.06852 | |
Remy de Vries | ||
Commitments And Contingencies [Line Items] | ||
Term of agreement | 2 years | 2 years |
Renewable period of agreement | 1 year | 1 year |
Notice period prior expiration | 30 days | 30 days |
Annual salary | € | € 120,000 | |
Increase in annual salary | € | € 150,000 | |
Number of customers have a minimum of 500 users of software system | Customer | 3 | 3 |
Performance bonus up to percentage of base salary | 75.00% | 75.00% |
Number of stock options granted | shares | 2,554,278 | 2,554,278 |
Vesting anniversaries of stock options | Anniversary | 3 | 3 |
Entitled period of paid vacation | Five weeks | Five weeks |
Monthly vehicle allowance limited upto annual base salary EURO 150,000 | € | € 1,350 | |
Terms of employment agreement termination | (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. | (i) be paid his then current base salary earned through the date of termination, together with all reimbursements and other amounts owed to him through such date pursuant, including any accrued but unused vacation/holiday time, (ii) an amount equal to one hundred percent (100%) of the greater of (A) his bonus for the year of termination or (B) the bonus actually earned for the year prior to the year of termination, if any, (iii) a lump-sum severance payment severance in an amount equal to the lesser of (A) one (1) times the base salary in the year of such termination or (B) the amount of base salary owed to him for the remainder of the first two years of his employment, (iv) we will continue to provide him with those medical, life and disability insurance benefits, if any, which are provided to him on the last day of his employment by us (or reimburse him for COBRA) for a period of five years, and (v) all stock options granted to him shall immediately vest, and any transfer restrictions thereon shall cease to be effective. |
Remy de Vries | Year 1 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | $ 0.04893 | |
Remy de Vries | Year 2 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | 0.05873 | |
Remy de Vries | Year 3 | ||
Commitments And Contingencies [Line Items] | ||
Vesting exercise price | $ 0.06852 |
SUBSEQUENT EVENTS (Detail Textu
SUBSEQUENT EVENTS (Detail Textuals) - USD ($) | May 12, 2017 | May 11, 2017 | Apr. 12, 2017 | May 02, 2017 | Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 |
Subsequent Event [Line Items] | |||||||
Proceeds from issuance of convertible notes | $ 135,846 | $ 250,000 | |||||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 | |||||
Number of shares issued | 1,365,000 | ||||||
Value of shares issued | $ 27,300 | ||||||
Subsequent Event | |||||||
Subsequent Event [Line Items] | |||||||
Number of shares issued upon conversion of debt | 10,272,988 | ||||||
Conversion of debt and accrued interest amount | $ 68,884 | ||||||
Subsequent Event | Series B Preferred Stock | |||||||
Subsequent Event [Line Items] | |||||||
Preferred stock, shares authorized | 1,500,000 | ||||||
Preferred stock, voting rights | 250 votes | ||||||
Preferred stock, voting percentage | 51.00% | ||||||
Subsequent Event | Series B Preferred Stock | Arend D. Verweij | |||||||
Subsequent Event [Line Items] | |||||||
Number of shares issued | 500,000 | ||||||
Value of shares issued | $ 500 | ||||||
Shares issued, price per share | $ 0.001 | ||||||
Subsequent Event | Series B Preferred Stock | Geurt van Wijk | |||||||
Subsequent Event [Line Items] | |||||||
Number of shares issued | 500,000 | ||||||
Value of shares issued | $ 500 | ||||||
Shares issued, price per share | $ 0.001 | ||||||
Subsequent Event | Series B Preferred Stock | Remy de Vries | |||||||
Subsequent Event [Line Items] | |||||||
Number of shares issued | 500,000 | ||||||
Value of shares issued | $ 500 | ||||||
Shares issued, price per share | $ 0.001 | ||||||
Subsequent Event | AUCTUS FUND, LLC | 10% Convertible Note | |||||||
Subsequent Event [Line Items] | |||||||
Principle amount of debt | $ 168,500 | ||||||
Convertible debt, interest rate | 10.00% | ||||||
Proceeds from issuance of convertible notes | $ 168,500 | ||||||
Convertible note, maturity date | Jan. 10, 2018 | ||||||
Interest rate if principal or interest on Note is not paid | 24.00% | ||||||
Conversion price | $ 0.04 | ||||||
Subsequent Event | Crown Bridge Partners, LLC | Promissory Notes | |||||||
Subsequent Event [Line Items] | |||||||
Principle amount of debt | $ 55,000 | ||||||
Convertible debt, interest rate | 1.00% | ||||||
Proceeds from issuance of convertible notes | $ 45,000 | ||||||
Convertible note, maturity date | Apr. 10, 2018 | ||||||
Interest rate if principal or interest on Note is not paid | 22.00% | ||||||
Rate of conversion | 75.00% | ||||||
Number of trading days | 20 days | ||||||
Minimum beneficial ownership percentage of outstanding common stock | 4.99% | ||||||
Maximum beneficial ownership percentage stated for conversion of debt | 9.99% | ||||||
Number of days for written notice | 61 days |